Frontiers reaches 6.4 on Journal Impact Factors
The birth of a new medical journal is always exciting and at the same time a great challenge. In particular, in pathology, in the recent years we are witnessing great changes that involve not only the technical aspects, but also the aims and the mission of our discipline. In this context, a new journal of pathology has to be not only a mere witness of this new wind, but must also perform an active role in the education of a new generation of pathologists through the reporting of high quality scientific observations and their active dissemination in the era of Web 2.0. Today, molecular pathology plays an increasing important role in most academic and many general practice departments.
Together with data derived from human genome project and striking technological improvements, the study of disease by means of molecular methods and the application of this knowledge to clinical diagnosis and prognosis are reshaping both biomedical research and general medical practice with a growing emphasis on personalized medicine. Furthermore, the exploding increase of high-throughput molecular techniques is also shifting the general approach to research from the traditional hypothesis-driven science toward a more demanding hypothesis-generating science.
On the other hand, the advent of molecular pathology does not mean the end for morphology–based pathology, which still remains the central core of our daily work. The Pathology section of Frontiers of Medicine aims to explore the scientific basis of human pathology by the publication of high quality research regarding diagnostic, prognostic and predictive topics in pathology. Evidence–based pathology will represent an important prerequisite. In the era of “stratified” and personalised medicine, manuscripts dealing with biomarkers studies are given high priority. Original manuscripts and review articles in the broad area of translational as well as basic research relevant to human clinical disease and exploring the mechanism and etiology of disease processes are also welcome. Clinicopathological case reports, including cases of autoptic pathology, are considered if they advance our understanding of pathophysiology and/or diagnostic practice of disease.
Indexed in: PubMed, PubMed Central, Google Scholar, DOAJ, Emerging Sources Citation Index, CLOCKSS
PMCID: all published articles receive a PMCID
Pathology welcomes submissions of the following article types: Case Report, Clinical Study Protocol, Clinical Trial, Community Case Study, Correction, Editorial, General Commentary, Mini Review, Original Research, Perspective, Protocols, Review and Systematic Review.
All manuscripts must be submitted directly to the section Pathology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Pathology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Medicine.